| Expression pattern: |
DN |
| Associated gene: |
- |
| Associated microRNA: |
- |
| Biological function: |
Potentially interferes with NSCLC progression (associated with lymph node metastasis and advanced stage). |
| Molecular mechanism: |
Not explored in depth in this study. |
| Biological pathway or process: |
not specified |
| Detected method: |
Q
M
|
| Validation methods: |
Microarray; RT-qPCR; Clinical Sample Validation; ROC Analysis; Survival Analysis; Cohort Study; Bioinformatics Analysis |
| Clinical significance: |
Low expression is associated with lymph node metastasis, advanced TNM stage, and adverse 3-year survival; diagnostic biomarker with AUC 0.887 and improved performance when combined with CEA or CYFRA21-1. |
| Description: |
hsa_circ_0072309 (LIFR) is down-regulated in NSCLC and is associated with lymph node metastasis, advanced stage, and poorer survival when expressed at low levels. It also shows diagnostic value (AUC 0.887), with improved performance when combined with CEA or CYFRA21-1; the mechanism was not deeply explored. |
| Confidence score: |
0.5734 |